Beximco Pharmaceuticals Ltd., a company listed on the stock exchanges, has declared a 47.5 percent cash dividend for the financial year ended June 30, 2025.
According to company sources, the pharmaceutical manufacturer reported earnings per share (EPS) of Tk 15.56 for the year, compared with Tk 13.07 in the previous financial year, reflecting improved profitability.
The company’s net operating cash flow per share (NOCFPS) stood at Tk 16.19, down from Tk 18.75 in the preceding year.
As of December 31, 2025, the company’s net asset value per share (NAVPS) was Tk 119.04.
Beximco Pharma has not yet finalized the date for its Annual General Meeting (AGM). The company said the AGM schedule will be determined following approval from the High Court.
The record date for entitlement to the declared dividend has been fixed for August 2, 2026.
